Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Treatment Outcome and Prognostic Factors of Korean Patients with Chronic Lymphocytic Leukemia: Multicenter Retrospective Study

Yunsuk Choi, MD PhD, Jung-Hee Lee, MD PhD, Chul Won Jung, MD PhD, Jin Seok Kim, Inho Kim, MD PhD, Silvia Park, MD, June-Won Cheong, MD, PhD, Seonyang Park, MD PhD, Sung-Yong Kim, Mark Hong Lee, MD PhD

Blood (2014) 124 (21): 5669.

https://doi.org/10.1182/blood.V124.21.5669.5669

Published: 2014

Journal Articles

Factors Affecting Clinical Outcomes after CLAG/CLAG-M Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia

Hyunkyung Park, MD, Jeonghwan Youk, MD, Youngil Koh, MD, Inho Kim, MD PhD, Seonyang Park, MD PhD, Jeong-Ok Lee, Soo-Mee Bang, Hyo Jung Kim, MD PhD, Hwi-Joong Yoon, MD PhD, Junglim Lee, MD, Sung-Soo Yoon, MD PhD

Blood (2014) 124 (21): 5289.

https://doi.org/10.1182/blood.V124.21.5289.5289

Published: 2014

Journal Articles

Mutation in Retinoic X Receptor-γ Is a Possible Mechanism of All-Trans Retinoic Acid Resistance in Acute Promyelocytic Leukemia(APL): Identifying Genetic Changes Related to Drug Resistance in APL Using Whole Exome Sequencing

Jeonghwan Youk, MD, Youngil Koh, MD, Hyunkyung Park, Dae-Yoon Kim, Chan-Soo Lee, Junglim Lee, MD, Hyo Jung Kim, MD PhD, Hwi-Joong Yoon, MD PhD, Kwang-Sung Ahn, PhD, Jong-Sun Jung, PhD, Inho Kim, MD PhD, Seonyang Park, MD PhD, Sung-Soo Yoon, MD PhD

Blood (2014) 124 (21): 2358.

https://doi.org/10.1182/blood.V124.21.2358.2358

Published: 2014

Journal Articles

A Multinational, Open-Label Phase 2 Study Of Ruxolitinib In Asian Patients (Pts) With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF)

Chul Won Jung, MD, PhD, Lee-Yung Shih, MD, Zhijian Xiao, MD, Jie Jin, MD, Hsin-An Hou, MD, Xin Du, MD, Ming-Chung Wang, MD, Seonyang Park, MD, PhD, Ki-Seong Eom, MD, PhD, Kenji Oritani, Shinichiro Okamoto, MD, PhD, Tetsuzo Tauchi, MD, Jin Seok Kim, MD, Daobin Zhou, MD, Andres Sirulnik, MD, PhD, Wanda Ruiz, PhD, Taro Amagasaki, PhD, Kazuo Ito, Koichi Akashi, MD, PhD

Blood (2013) 122 (21): 4086.

https://doi.org/10.1182/blood.V122.21.4086.4086

Published: 2013

Journal Articles

Application Of The Revised International Prognostic Scoring System In Korean Patients With MDS and Clinical Significance Of Clonal Evolution

Jae Hyeon Park, MD, Si Nae Park, Jiseok Kwon, Kyongok Im, Jung Ah Kim, MD, Qute Choi, MD, Seon Young Kim, MD, Sang Mee Hwang, MD, Inho Kim, Sung-Soo Yoon, Seonyang Park, MD, PhD, Dong Soon Lee, MD, PhD

Blood (2013) 122 (21): 5217.

https://doi.org/10.1182/blood.V122.21.5217.5217

Published: 2013

Journal Articles

Restrospective Multicenter Study Evaluating Efficacy and Safety of Dasatinib and Nilotinib in Patients with Imatinib-Resistant or –intolerant Chronic Myeloid Leukemia in Chronic Phase: Korean CML Working Party

Blood (2012) 120 (21): 1691.

https://doi.org/10.1182/blood.V120.21.1691.1691

Published: 2012

Journal Articles

A Retrospective Study to Evaluate the Survival Rates in R-CHOP Chemotherapy Followed by Autologous Stem Cell Transplantation for the Treatment of Diffuse Large B Cell Lymphoma

Mark H. Lee, MD., PhD., Sung-Yong Kim, MD.PhD., Inho Kim, MD, PhD, Seonyang Park, MD, PhD, Yeo-Kyeoung Kim, MD.PhD., Yang Soo Kim, MD.PhD., Ho Sup Lee, MD, Jeong-A Kim, MD.PhD., Jinny Park, MD.PhD., Seok Jin Kim, MD, PhD, Sung Kyu Park, MD.PhD., Byeong-Bae Park, MD.PhD., Hyeok Shim, MD.PhD., Hyeon Seok Eom, MD, Junglim Lee, MD

Blood (2012) 120 (21): 4517.

https://doi.org/10.1182/blood.V120.21.4517.4517

Published: 2012

Journal Articles

Clinical Efficacy of Mitoxantrone-Based Salvage Chemotherapy in Adult Patients with Relapsed or Refractory All; Retrospective Multicenter Study of Korean Adult ALL Working Party

Jae-Sook Ahn, MD, PhD, Deok-Hwan Yang, MD, PhD, Sung-Hoon Jung, MD, Je-Jung Lee, MD, PhD, Inho Kim, MD, PhD, Seonyang Park, MD, PhD, Joo-Seop Jung, Ho-Jin Shin, Dae-Young Kim, Kyoo-Hyung Lee, Joon Ho Moon, MD, Sang Kyun Sohn, MD, Ik-Chan Song, Deog Yeon Jo

Blood (2012) 120 (21): 4306.

https://doi.org/10.1182/blood.V120.21.4306.4306

Published: 2012

Journal Articles

Head-to-Head Comparison of 5-Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndrome.

Yun-Gyoo Lee, Inho Kim, MD, PhD, Sung-Soo Yoon, MD, PhD, Seonyang Park, MD, PhD, June-Won Cheong, MD, PhD, Yoo-Hong Min, MD, PhD, Soo-Mee Bang, MD, PhD, Chul Soo Kim, Yong Park, MD, Yeung Chul Mun, Jinny Park, Jae Hoon Lee, Hong Ghi Lee, Yeo-Kyeoung Kim, MD.PhD., Hyeoung-Joon Kim, MD, PhD

Blood (2012) 120 (21): 2843.

https://doi.org/10.1182/blood.V120.21.2843.2843

Published: 2012

Journal Articles

Increased Copy Number of Interleukin-6 Receptor Gene Is Associated with Adverse Survival In Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation

Seon Young Kim, MD, Hyun Jung Min, Hyun Kyung Park, MD, Bora Oh, Tae Young Kim, Hyun Kyung Kim, MD, PhD, Inho Kim, MD, PhD, Sung-Soo Yoon, MD, PhD, Seonyang Park, MD, PhD, Byoung Kook Kim, MD, PhD, Dong Soon Lee, MD, PhD

Blood (2010) 116 (21): 1895.

https://doi.org/10.1182/blood.V116.21.1895.1895

Published: 2010

Journal Articles

The Relationship of JAM2 Polymorphisms and Graft-Versus-Host-Disease (GVHD) after Allogeneic Stem Cell Transplantation

Eunkyung Park, MD, PhD, Sung-Hyo Park, BS, Kyu-Hyoung Lim, Ji Ae Song, Inho Kim, MD, PhD, Sung-Soo Yoon, MD, PhD, Seonyang Park, MD, PhD

Blood (2008) 112 (11): 4342.

https://doi.org/10.1182/blood.V112.11.4342.4342

Published: 2008

Journal Articles

Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms of Both Donor and Recipient Can Modify the Rate of Recurrence in Allogeneic Hematopoietic Stem Cell Transplantation.

So Yeon Oh, MD, Hye Jin Kim, MD, Hyeon Gyu Yi, MD, Jin Won Kim, MD, Cheng Zhe Piao, PhD, Chongwon Chang, Eunsoon Shin, PhD, Inho Kim, MD, PhD, Sung-Soo Yoon, MD, PhD, Seonyang Park, MD, PhD, Byoung Kook Kim, MD, PhD

Blood (2007) 110 (11): 4933.

https://doi.org/10.1182/blood.V110.11.4933.4933

Published: 2007

Journal Articles

Blockage of IL-6 Mediated JAK2/STAT3 Cell Signaling Pathway by sIL-6R Effectively Inhibited the Growth of Multiple Myeloma Cell.

Ju-won Park, BA, Kwang-Sung Ahn, PhD, Young-Ju Kim, BA, Eunkyung Bae, MS, Yong-Yeol Lee, MD PhD, Sung-Soo Yoon, MD PhD, Inho Kim, MD PhD, Seonyang Park, MD PhD, Byoung-Kook Kim, MD PhD

Blood (2006) 108 (11): 5083.

https://doi.org/10.1182/blood.V108.11.5083.5083

Published: 2006

Journal Articles

Pharmacokinetics and Tolerability of Intravenous Busulfan in Hematopoietic Stem Cell Transplantation.

Sung-Soo Yoon, MD, PhD, Yo-Han Cho, MD, Hyun-Ae Lim, Inho Kim, MD, Soo-Mee Bang, MD, Jong Seok Lee, MD, Seonyang Park, MD, PhD, Byoung KooK Kim, MD, PhD

Blood (2006) 108 (11): 5249.

https://doi.org/10.1182/blood.V108.11.5249.5249

Published: 2006

Journal Articles

IgH Gene Rearrangements Are Strongly Associated with Hyperdiploidy Variant Multiple Myeloma in Korea: A Contradiction to the Pathogenetic Pathway of IgH Tranlocations in Non Hyperdiploidy Variant.

Hee Won Moon, MD, Tae Young Kim, Seong- Ho Kang, MD, Hyun-Sook Chi, MD/PhD, Eul Zu Seo, MD/PhD, Chan Jeoung Park, MD/PhD, Honggu Chun, MD/PhD, Hee Chan Kim, MD/PhD, Sung-Soo Yoon, MD/PhD, Seonyang Park, MD/PhD, Byoung Kook Kim, MD/PhD, Han Ik Cho, MD/PhD, Dong Soon Lee, MD/PhD.

Blood (2005) 106 (11): 5084.

https://doi.org/10.1182/blood.V106.11.5084.5084

Published: 2005

Journal Articles

The Residual Malignant Cells Could Be Masked by Therapeutic Use of Granulocyte-Colony Stimulating Factor in the Patients with AML1/ETO + Acute Myelogenous Leukemia.

Hee Won Moon, MD, Ho Young Kim, Young Ree Kim, MD, Han Ik Cho, MD, PhD, Sung-Soo Yoon, MD, PhD, Seonyang Park, MD, PhD, Byoung Kook Kim, MD, PhD, Honggu Chun, MD, PhD, Hee Chan Kim, MD, PhD, Dong Soon Lee, MD, PhD

Blood (2005) 106 (11): 4512.

https://doi.org/10.1182/blood.V106.11.4512.4512

Published: 2005

Journal Articles

Incidences of Submicroscopic Deletions Are Variable According to Disease Entities and Chromosomal Translocations in Hematologic Malignancies: Investigation by FISH.

Hyun Jung Min, Hee Won Moon, MD, Young-Ree Kim, MD/PhD, Sung-Soo Yoon, MD/PhD, SeonYang Park, MD/PhD, Byoung Kook Kim, MD/PhD, Hee Young Shin, MD/PhD, Hyo Sup Ahn, MD/PhD, Hee Chan Kim, MD/PhD, Han Ik Cho, MD/PhD, Dong Soon Lee, MD/PhD

Blood (2005) 106 (11): 4477.

https://doi.org/10.1182/blood.V106.11.4477.4477

Published: 2005

Journal Articles

Novel Synthetic Histone Deacetylase Inhibitor (SK-7041) Potently Inhibits Proliferation in Acute Myeloid Leukemia Cell Lines.

Young-Ju Kim, MS, Susan Guo, BA, Ju Won Park, BA, Eun Kyung Bae, MS, Kwang-Sung Ahn, PhD, Inho Kim, MD, PhD, Jong-Seok Lee, MD, PhD, Young Yiul Lee, MD, PhD, Seonyang Park, MD, PhD, Byoung Kook Kim, MD, PhD, Sung-Soo Yoon, MD, PhD

Blood (2005) 106 (11): 4407.

https://doi.org/10.1182/blood.V106.11.4407.4407

Published: 2005

Journal Articles

Proteasome Inhibitors Can Induce Caspase-3 Activation and Apoptosis in Human CML Cell Lines.

Byung-Su Kim, MD, Chang Up Kim, MD, Young-Ju Kim, BS, Eun Kyung Bae, MS, Jinhee Kim, BS, Kwang-Sung Ahn, PhD, Seonyang Park, MD, PhD, Byoung Kook Kim, MD, PhD, Sung-Soo Yoon, MD, PhD

Blood (2004) 104 (11): 4681.

https://doi.org/10.1182/blood.V104.11.4681.4681

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Treatment Outcome and Prognostic Factors of Korean Patients with Chronic Lymphocytic Leukemia: Multicenter Retrospective Study

Factors Affecting Clinical Outcomes after CLAG/CLAG-M Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia

Mutation in Retinoic X Receptor-γ Is a Possible Mechanism of All-Trans Retinoic Acid Resistance in Acute Promyelocytic Leukemia(APL): Identifying Genetic Changes Related to Drug Resistance in APL Using Whole Exome Sequencing

A Multinational, Open-Label Phase 2 Study Of Ruxolitinib In Asian Patients (Pts) With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF)

Application Of The Revised International Prognostic Scoring System In Korean Patients With MDS and Clinical Significance Of Clonal Evolution

Restrospective Multicenter Study Evaluating Efficacy and Safety of Dasatinib and Nilotinib in Patients with Imatinib-Resistant or –intolerant Chronic Myeloid Leukemia in Chronic Phase: Korean CML Working Party

A Retrospective Study to Evaluate the Survival Rates in R-CHOP Chemotherapy Followed by Autologous Stem Cell Transplantation for the Treatment of Diffuse Large B Cell Lymphoma

Clinical Efficacy of Mitoxantrone-Based Salvage Chemotherapy in Adult Patients with Relapsed or Refractory All; Retrospective Multicenter Study of Korean Adult ALL Working Party

Head-to-Head Comparison of 5-Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndrome.

Increased Copy Number of Interleukin-6 Receptor Gene Is Associated with Adverse Survival In Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation

The Relationship of JAM2 Polymorphisms and Graft-Versus-Host-Disease (GVHD) after Allogeneic Stem Cell Transplantation

Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms of Both Donor and Recipient Can Modify the Rate of Recurrence in Allogeneic Hematopoietic Stem Cell Transplantation.

Blockage of IL-6 Mediated JAK2/STAT3 Cell Signaling Pathway by sIL-6R Effectively Inhibited the Growth of Multiple Myeloma Cell.

Pharmacokinetics and Tolerability of Intravenous Busulfan in Hematopoietic Stem Cell Transplantation.

IgH Gene Rearrangements Are Strongly Associated with Hyperdiploidy Variant Multiple Myeloma in Korea: A Contradiction to the Pathogenetic Pathway of IgH Tranlocations in Non Hyperdiploidy Variant.

The Residual Malignant Cells Could Be Masked by Therapeutic Use of Granulocyte-Colony Stimulating Factor in the Patients with AML1/ETO + Acute Myelogenous Leukemia.

Incidences of Submicroscopic Deletions Are Variable According to Disease Entities and Chromosomal Translocations in Hematologic Malignancies: Investigation by FISH.

Novel Synthetic Histone Deacetylase Inhibitor (SK-7041) Potently Inhibits Proliferation in Acute Myeloid Leukemia Cell Lines.

Proteasome Inhibitors Can Induce Caspase-3 Activation and Apoptosis in Human CML Cell Lines.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only